Company intelligence / Profile preview

Qingdao Huashan Biochemical

Qingdao, Shandong, Chinaibsa-pharma.cn ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Qingdao Huashan Biochemical operates GMP-certified manufacturing facilities specializing in the production of intermediate pharmaceutical products, particularly focusing on the extraction and processing of hormones from urine. The company plays a strategic role in IBSA’s global supply chain for hormone-based therapies. No clinical trial results are directly reported as it is primarily a manufacturing site.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Small moleculeProtein
Industry: Contract Manufacturing Organization

Drug pipeline

2 assets

human chorionic gonadotropin

Commercial

Indications: Fertility

1 more asset in the full pipeline.

Request access →

Partnerships

IBSA Group

Beyond the preview

Go deeper on Qingdao Huashan Biochemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao Huashan Biochemical.

Explore the full profile